Tumor-Induced Senescent T Cells (TIST): a dysfunctional T cells population with Immunomodulatory ptential

RAMELLO MC; CANALE F; TOSELLO BOARI J; ACOSTA RODRIGUEZ EV; MONTES CL

Mar del Plata

Congreso; LIX Reunión Científica Anual de la Sociedad Argentina de Investigación Clínica. LXII Reunión Anual de la Sociedad Argentina de Inmunologia; 2014

SAI-SAIC

Senescent T cells are reported to be increased in patients with cancer. Previously, we have demonstrated that CD4+ and CD8+ T cells from healthy donors, after in vitro co-incubation with a tumor cell line, undergo senescence characterized by the loss of costimulatory molecules expression (CD27-CD28-) and telomere shortening. Herein we show that CD4+ and CD8+ tumor-induced senescent T (TIS-T) cells were unable to produce cytokines such as IL-2, IFNg and TNF after polyclonal stimulation. Although CD8+ control T cells (T cells without tumor co-incubation) and CD8+ TIS-T cells showed similar intracellular expression of granzymes B and A, degranulation in CD8+ TIS-T cells was significantly lower than in CD8+ control T cells after PMA/Ionomycin stimulation (p=0.024). In concordance, we observed that CD4+ and CD8+ TIS-T cells significantly down-regulated the expression of TCR-CD3 zeta-chain (p